Table 1 Baseline Characteristics of the study population between eradicated group, sustained infection group, no infection group.
From: Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia
Eradicated group (n = 26) | Sustained infection group (n = 10) | No infection group (n = 25) | P-value | ||||
|---|---|---|---|---|---|---|---|
N | Mean ± SD | N | Mean ± SD | N | Mean ± SD | ||
Age (year) | 26 | 52.5 ± 12.3 | 10 | 56.0 ± 16.6 | 25 | 48.9 ± 20.2 | 0.490† |
Sex (male) | 8 | 30.8% | 4 | 40.0% | 9 | 36.0% | 0.853* |
Platelet, × 109/L [range] | 26 | 50.2 ± 23.5 [8–89] | 10 | 63.3 ± 33.9 [21–98] | 25 | 60.6 ± 23.4 [27–87] | 0.238† |
MPV, fL | 22 | 10.9 ± 2.1 | 7 | 11.8 ± 1.2 | 24 | 11.2 ± 2.7 | 0.680† |
WBC, × 103/uL | 26 | 8.0 ± 2.7 | 10 | 5.7 ± 1.9 | 25 | 5.6 ± 2.0 | 0.002† |
Neutrophil, × 103/uL | 26 | 5.2 ± 2.3 | 10 | 3.2 ± 1.4 | 25 | 3.0 ± 1.5 | 0.000† |
Lymphocyte, × 103/uL | 26 | 2.2 ± 1.1 | 10 | 2.4 ± 0.9 | 25 | 1.8 ± 0.8 | 0.146† |
Monocyte, × 103/uL | 26 | 0.4 ± 0.2 | 10 | 0.5 ± 0.2 | 25 | 0.5 ± 0.7 | 0.589† |
Eosinophil, × 103/uL | 26 | 0.2 ± 0.4 | 10 | 0.1 ± 0.1 | 24 | 0.1 ± 0.1 | 0.554† |
Basophil, × 103/uL | 26 | 0.0 ± 0.0 | 9 | 0.0 ± 0.0 | 24 | 0.0 ± 0.0 | 0.510† |
Haemoglobin, g/dL | 26 | 12.7 ± 2.7 | 10 | 13.2 ± 2.8 | 25 | 13.2 ± 1.7 | 0.760† |
Reticulocyte, g/dL | 15 | 72.6 ± 27.7 | 3 | 39.8 ± 6.4 | 14 | 62.4 ± 13.8 | 0.059† |
NLR | 26 | 2.8 ± 3.2 | 10 | 1.4 ± 0.5 | 25 | 1.8 ± 0.9 | 0.144† |
Antinuclear antibody positivity | 2 | 15.4% (2/13) | 1 | 14.3% (1/7) | 7 | 38.9% (7/18) | 0.248* |
CRP, mg/dL | 13 | 0.8 ± 1.5 | 8 | 1.6 ± 3.3 | 17 | 0.6 ± 1.6 | 0.504† |
ESR, mm/h | 10 | 24.3 ± 25.9 | 8 | 22.8 ± 35.1 | 13 | 17.3 ± 15.2 | 0.781† |
